Additional file 5: of Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma

Simon, Thomas;Pinioti, Sotiria;Schellenberger, Pascale;Vinothini Rajeeve;Wendler, Franz;Cutillas, Pedro;King, Alice;Stebbing, Justin;Giamas, Georgios

Description

Supplementary Figure 3. Bevacizumab is detectable in GBM cells and on GBM cells-derived EVs following treatment. (ZIP 1930 kb)

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.9

FAIR Score

85%

Citations

1

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

figshare

License

Creative Commons Attribution 4.0 International

Assigned Domain

Subfield

Immunology

Field

Immunology and Microbiology

Domain

Life Sciences

Confidence Score

61%

Source

Scholar Data Model

Keywords

BiophysicsBiochemistryCell BiologyMolecular BiologyPharmacology69999 Biological Sciences not elsewhere classifiedFOS: Biological sciences80699 Information Systems not elsewhere classifiedFOS: Computer and information sciencesDevelopmental BiologyCancerHematology110309 Infectious DiseasesFOS: Health sciences60506 Virology

Normalization Factors

FT

51.92

CTw

1.00

MTw

1.00